Dhiti Omics

Dhiti Omics is a precision molecular diagnostics service provider specializing in Rare Disease, Inherited Disorders, Oncology, Pharmacogenomics, and Infectious Disease diagnosis. Utilizing state-of-the-art genomics technologies such as Next Generation Sequencing, Microarrays, Sanger Sequencing, PCR and qRT-PCR, the company aims to offer deeper insights into the diagnosis of rare and difficult diseases. Founded in 2014 and headquartered in India, Dhiti Omics collaborates with subject matter experts to provide genomic-based clinical diagnostics and research services. The company's focus lies on early disease detection, risk stratification, prognostication, and the prediction of therapy response. Dhiti Omics secured its Seed Round investment on 30 March 2016. With its specialization in the biotechnology and healthcare industries, this startup is poised to make significant strides in precision medicine and genetic testing.